Novel contrast agents work by enhancing the differences in signal intensity between normal and abnormal tissues. For example, MRI contrast agents typically alter the relaxation times of hydrogen protons in water molecules within tissues, thereby highlighting areas with higher or lower concentrations of the agent. In PET scans, radiolabeled agents emit positrons that collide with electrons, producing gamma rays detected by the scanner.
